Real‐world evidence and biomarkers in allergic diseases.

This article discusses three studies related to allergic diseases. The first study focuses on subcutaneous immunotherapy using pollen allergoid tyrosine adsorption, which has been shown to have long-term clinical benefits for individuals with allergic rhinitis and asthma. The second study analyzes the impact of allergen immunotherapy on the progression of allergic rhinitis and the need for asthma medication. The study found that patients who received immunotherapy had fewer prescriptions for allergy and asthma medications compared to the control group. The third study introduces a novel assay that measures the affinity of allergen-specific IgG antibodies following immunotherapy. The study found that individuals with reduced apple allergy had higher collective binding strength of protective antibodies compared to those without reduced apple allergy. These findings provide valuable insights into the treatment and management of allergic diseases. [Extracted from the article]